"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","59/99","499/2914",3.40858443466421e-22,1.1749400899906e-19,7.62451739104753e-20,"AKT1/AR/CCNE1/CDK2/CDK4/CSNK2A1/CTNNB1/E2F1/ESR1/FBXW7/FOXO1/JUN/MAPK3/NCOR2/PRKACA/TP53/UBE2I/YWHAQ/YWHAZ/ATR/CREB1/CREBBP/E2F4/EGFR/GATA3/LEF1/MYC/NR3C1/RBL1/SMAD3/SMAD4/SPI1/TOPBP1/MAPK1/SFN/WWTR1/YAP1/AKT3/KAT2B/MAPK14/MDM2/PARP1/RARA/SUMO1/TWIST1/GATA2/MYBL2/FOXO3/TCF7/TCF7L2/ESR2/FOS/POU2F1/KMT2A/PPARG/RUNX2/ATF2/TEAD1/MYB",59
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","58/99","481/2914",3.72405733752964e-22,1.1749400899906e-19,7.62451739104753e-20,"AKT1/AR/CCNE1/CDK2/CDK4/CSNK2A1/CTNNB1/E2F1/ESR1/FBXW7/FOXO1/JUN/MAPK3/NCOR2/PRKACA/TP53/UBE2I/YWHAQ/YWHAZ/ATR/CREB1/CREBBP/E2F4/EGFR/GATA3/LEF1/MYC/NR3C1/RBL1/SMAD3/SMAD4/SPI1/TOPBP1/MAPK1/SFN/WWTR1/YAP1/AKT3/KAT2B/MAPK14/MDM2/PARP1/RARA/SUMO1/TWIST1/GATA2/MYBL2/FOXO3/TCF7/TCF7L2/ESR2/FOS/KMT2A/PPARG/RUNX2/ATF2/TEAD1/MYB",58
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","13/99","27/2914",4.91317617220858e-13,9.90966258029341e-11,6.43065934395552e-11,"CDK2/CDK4/E2F1/CREB1/LEF1/MYC/SPI1/STAT3/RARA/GATA2/KMT2A/CEBPA/MYB",13
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","42/99","397/2914",6.281878022373e-13,9.90966258029341e-11,6.43065934395552e-11,"AKT1/CDK2/CDK4/CSNK2A1/CTNNB1/E2F1/FOXO1/JUN/MAPK3/MAPK8/NCOR2/PRKACA/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/CREB1/CREBBP/EGFR/LEF1/MYC/NR2F2/PIK3R1/SMAD3/SMAD4/SPI1/STAT3/MAPK1/SHC1/AKT3/KAT2B/MAPK14/RARA/GATA2/FOXO3/KMT2A/PPARG/CEBPA/NFKB1/RELA/MYOD1/MYB",42
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","22/99","108/2914",2.16593933683443e-12,2.73341544308505e-10,1.77379032006019e-10,"AKT1/ESR1/JUN/MAPK3/CREB1/CREBBP/EGFR/GATA3/MYC/PIK3R1/ELK1/MAPK1/SHC1/AKT3/KAT2B/NRIP1/FOXO3/ESR2/FOS/POU2F1/ATF2/MYB",22
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","13/99","30/2914",2.69721951507992e-12,2.83657585669238e-10,1.84073401994051e-10,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/ELK1/MAPK1/MAPK10/MAPK14/FOS/ATF2",13
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","24/99","136/2914",4.97361937781861e-12,4.48336261057649e-10,2.90938035785179e-10,"AKT1/ESR1/JUN/MAPK3/NCOR2/CREB1/CREBBP/EGFR/GATA3/MYC/PIK3R1/ELK1/MAPK1/SHC1/AKT3/KAT2B/NRIP1/RARA/FOXO3/ESR2/FOS/POU2F1/ATF2/MYB",24
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","8/99","10/2914",5.70137611664993e-11,4.49696041200763e-09,2.91820435444319e-09,"JUN/MAPK3/MAPK8/MAPK1/MAPK10/MAPK14/FOS/ATF2",8
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","15/99","53/2914",6.87949391131715e-11,4.82328962004569e-09,3.12996857485657e-09,"CTNNB1/TP53/CREBBP/LEF1/MYC/SMAD3/SMAD4/WWTR1/YAP1/KAT2B/MDM2/FOXO3/TCF7/TCF7L2/TEAD1",15
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","17/99","78/2914",3.10006101104285e-10,1.63011541497337e-08,1.05782783622427e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","17/99","78/2914",3.10006101104285e-10,1.63011541497337e-08,1.05782783622427e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","17/99","78/2914",3.10006101104285e-10,1.63011541497337e-08,1.05782783622427e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-450294","R-HSA-450294","MAP kinase activation","15/99","60/2914",4.82023659120241e-10,2.33966868388363e-08,1.51827695058926e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/ATF2",15
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","34/99","332/2914",6.60322364929906e-10,2.9761672305055e-08,1.93131879667469e-08,"AKT1/FOXO1/JUN/MAPK3/MAPK8/PRKACA/RPS6KA1/RPS6KA2/RPS6KA5/TP53/YWHAZ/CREB1/GATA3/MYC/PIK3R1/PTGS2/SMAD3/STAT3/SYK/VAV1/APP/ELK1/MAPK1/MAPK10/SHC1/MAPK14/TRAF6/TWIST1/FOXO3/FOS/POU2F1/NFKB1/RELA/ATF2",34
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","17/99","83/2914",8.77751270236757e-10,3.69240701012929e-08,2.39610697629543e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","17/99","84/2914",1.07058992925099e-09,3.97377791386692e-08,2.57869648593583e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","17/99","84/2914",1.07058992925099e-09,3.97377791386692e-08,2.57869648593583e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","15/99","64/2914",1.29332811685111e-09,4.53383356518361e-08,2.94213238277825e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/ATF2",15
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","17/99","86/2914",1.57858811596794e-09,4.74328143417033e-08,3.07804900807784e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","17/99","86/2914",1.57858811596794e-09,4.74328143417033e-08,3.07804900807784e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","17/99","86/2914",1.57858811596794e-09,4.74328143417033e-08,3.07804900807784e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","17/99","87/2914",1.90866252541306e-09,5.01819188973184e-08,3.25644615081439e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","17/99","87/2914",1.90866252541306e-09,5.01819188973184e-08,3.25644615081439e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","17/99","87/2914",1.90866252541306e-09,5.01819188973184e-08,3.25644615081439e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","18/99","99/2914",2.06570401768526e-09,5.2138369406376e-08,3.38340573844028e-08,"CCNE1/CDK2/CDK4/E2F1/JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/TP53/STAT3/MAPK1/MAPK10/MAPK14/MDM2/FOS/NFKB1/RELA",18
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","17/99","90/2914",3.31918764497610e-09,7.75706445918487e-08,5.03377775397934e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","17/99","90/2914",3.31918764497610e-09,7.75706445918487e-08,5.03377775397934e-08,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","14/99","62/2914",8.19724506514744e-09,1.84730772718144e-07,1.19877004900088e-07,"AKT1/AR/CDK4/ESR1/FBXW7/MAPK3/NR3C1/SMAD4/MAPK1/WWTR1/YAP1/AKT3/TWIST1/RUNX2",14
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","7/99","11/2914",1.24935188156347e-08,2.71841736988464e-07,1.76405764765223e-07,"AKT1/FOXO1/YWHAQ/YWHAZ/SFN/AKT3/FOXO3",7
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","23/99","187/2914",2.60451305986825e-08,5.47815913592288e-07,3.55493186066227e-07,"AR/CCNE1/CDK2/CDK4/E2F1/JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/TP53/ATR/CREBBP/NR3C1/STAT3/MAPK1/MAPK10/MAPK14/MDM2/FOS/ARNT/NFKB1/RELA",23
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","23/99","189/2914",3.20278406843233e-08,6.51921531348644e-07,4.23050255558633e-07,"AR/CCNE1/CDK2/CDK4/E2F1/JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/TP53/ATR/CREBBP/NR3C1/STAT3/MAPK1/MAPK10/MAPK14/MDM2/FOS/ARNT/NFKB1/RELA",23
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","9/99","24/2914",3.59115015421928e-08,7.08129921035115e-07,4.59525463812928e-07,"AKT1/MAPK3/CREB1/EGFR/ELK1/MAPK1/AKT3/FOXO3/FOS",9
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","12/99","49/2914",3.93621250512435e-08,7.52651542646504e-07,4.88416798881458e-07,"AKT1/FOXO1/YWHAQ/YWHAZ/CREBBP/NR3C1/SMAD3/SMAD4/SFN/AKT3/KAT2B/FOXO3",12
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","8/99","19/2914",7.42817558281876e-08,1.37858199787019e-06,8.94600712605726e-07,"CCNE1/CDC25A/CDK2/E2F1/E2F4/MYC/RBL1/MYBL2",8
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","17/99","110/2914",7.89127724005081e-08,1.42268455384916e-06,9.23220104174365e-07,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","26/99","249/2914",8.53909063086361e-08,1.49671283002082e-06,9.71259139007586e-07,"AKT1/CCNE1/CDC25A/CDK2/CDK4/CSNK1E/CSNK2A1/E2F1/MAPK3/PRKACA/TP53/UBE2I/YWHAQ/YWHAZ/ATR/E2F4/MYC/RBL1/TOPBP1/MAPK1/SFN/AKT3/MDM2/SUMO1/MYBL2/FOXM1",26
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","13/99","63/2914",9.33724904822317e-08,1.59237949984563e-06,1.03333993734248e-06,"AKT1/ESR1/MAPK3/CREB1/EGFR/PIK3R1/ELK1/MAPK1/SHC1/AKT3/FOXO3/ESR2/FOS",13
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","11/99","44/2914",1.20419516518663e-07,1.99959776113885e-06,1.29759534420387e-06,"CDK4/E2F1/JUN/MAPK3/MAPK8/TP53/MAPK1/MAPK10/MAPK14/MDM2/FOS",11
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","11/99","45/2914",1.54935162966662e-07,2.50677148287086e-06,1.62671466650557e-06,"CDK2/CDK4/JUN/MAPK3/RPS6KA1/RPS6KA2/STAT3/MAPK1/FOS/NFKB1/RELA",11
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","9/99","30/2914",3.31621894344295e-07,5.23133538328126e-06,3.39476097105081e-06,"JUN/MAPK3/MAPK8/SYK/VAV1/MAPK1/MAPK10/SHC1/FOS",9
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","11/99","49/2914",3.97150297903642e-07,5.96671042802853e-06,3.87196656352173e-06,"AKT1/E2F1/MAPK3/MAPK8/TP53/YWHAQ/YWHAZ/STAT3/MAPK1/SFN/AKT3",11
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","11/99","49/2914",3.97150297903642e-07,5.96671042802853e-06,3.87196656352173e-06,"ESR1/JUN/CREBBP/GATA3/MYC/KAT2B/NRIP1/FOS/POU2F1/ATF2/MYB",11
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","8/99","24/2914",6.27738887582979e-07,9.21170321081069e-06,5.97773383769348e-06,"MAPK3/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/ELK1/MAPK1/MAPK14",8
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","20/99","172/2914",6.43035909660618e-07,9.22171952263296e-06,5.98423370473637e-06,"AKT1/CSNK2A1/ESR1/FOXO1/JUN/MAPK3/TP53/CREB1/EGFR/EGR1/PIK3R1/VAV1/MAPK1/AKT3/MDM2/TRAF6/FOXO3/ESR2/PPARG/ATF2",20
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","17/99","127/2914",6.80369107999749e-07,9.54028682550759e-06,6.19096100612637e-06,"JUN/MAPK3/MAPK8/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/APP/ELK1/MAPK1/MAPK10/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",17
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","25/99","268/2914",1.46375493642504e-06,2.00788992366131e-05,1.30297636217241e-05,"AKT1/CTNNB1/ESR1/FBXW7/FOXO1/MAPK3/NCOR2/CREB1/CREBBP/EGFR/MYC/PIK3R1/SMAD3/SMAD4/STAT3/VAV1/MAPK1/SHC1/AKT3/CTBP1/KAT2B/MDM2/FOXO3/TCF7L2/ESR2",25
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","15/99","107/2914",1.83931077313947e-06,2.46937254861917e-05,1.60244544401177e-05,"AR/ESR1/NCOR2/TP53/UBE2I/CREBBP/NR3C1/CTBP1/MDM2/NRIP1/PARP1/RARA/SUMO1/PPARG/RELA",15
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","21/99","201/2914",1.96403545387287e-06,2.58188827373705e-05,1.67546006920296e-05,"AKT1/CSNK2A1/ESR1/FOXO1/JUN/MAPK3/PRKACA/TP53/CREB1/EGFR/EGR1/PIK3R1/VAV1/MAPK1/AKT3/MDM2/TRAF6/FOXO3/ESR2/PPARG/ATF2",21
"R-HSA-2990846","R-HSA-2990846","SUMOylation","15/99","109/2914",2.34170662438986e-06,3.01554465304082e-05,1.95687191597778e-05,"AR/ESR1/NCOR2/TP53/UBE2I/CREBBP/NR3C1/CTBP1/MDM2/NRIP1/PARP1/RARA/SUMO1/PPARG/RELA",15
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","8/99","29/2914",3.18172679140304e-06,4.01533921075064e-05,2.60566678285428e-05,"AKT1/E2F1/MAPK8/TP53/YWHAQ/YWHAZ/SFN/AKT3",8
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","7/99","21/2914",3.32569948014447e-06,4.11473798425718e-05,2.67016944845449e-05,"MAPK3/RPS6KA1/RPS6KA2/RPS6KA5/ELK1/MAPK1/MAPK14",7
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","9/99","39/2914",3.80812960626676e-06,4.6210188106814e-05,2.99870934582545e-05,"AKT1/CCNE1/CDC25A/CDK2/CDK4/E2F1/E2F4/MYC/AKT3",9
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","20/99","194/2914",4.46492821132639e-06,5.31579188933387e-05,3.44956717816478e-05,"AKT1/CCNE1/CDK2/CSNK2A1/E2F1/JUN/TP53/YWHAQ/YWHAZ/ATR/CREBBP/E2F4/RBL1/TOPBP1/SFN/AKT3/MAPK14/MDM2/FOS/ATF2",20
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","13/99","87/2914",4.64018356152485e-06,5.422140420967e-05,3.51857973768648e-05,"JUN/MAPK3/MAPK8/PIK3R1/SYK/VAV1/MAPK1/MAPK10/SHC1/TRAF6/FOS/NFKB1/RELA",13
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","9/99","40/2914",4.77671278292069e-06,5.48019230185992e-05,3.55625123934191e-05,"AKT1/CCNE1/CDC25A/CDK2/CDK4/E2F1/E2F4/MYC/AKT3",9
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","8/99","31/2914",5.52730220190694e-06,6.22808515964872e-05,4.04157999349963e-05,"AKT1/CTNNB1/YWHAZ/LEF1/CTBP1/TCF7/TCF7L2/SOX6",8
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","14/99","104/2914",6.89080179224274e-06,7.62823847527223e-05,4.95017894216515e-05,"AKT1/E2F1/FBXW7/JUN/NCOR2/TP53/YWHAZ/CREB1/CREBBP/EGFR/MYC/SMAD3/KAT2B/IKZF1",14
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/99","24/2914",9.10101179565539e-06,9.90127317768715e-05,6.42521522415598e-05,"AR/MAPK3/SMAD4/MAPK1/WWTR1/YAP1/RUNX2",7
"R-HSA-1643685","R-HSA-1643685","Disease","32/99","443/2914",1.07554225935008e-05,0.000115028333161,7.46451273661337e-05,"AKT1/CDC25A/CDK4/CTNNB1/ESR1/FBXW7/FOXO1/JUN/MAPK3/NCOR2/PRKACA/CREB1/CREBBP/EGFR/MYC/PIK3R1/SMAD3/SMAD4/STAT3/VAV1/APP/MAPK1/SHC1/AKT3/CTBP1/KAT2B/MDM2/FOXO3/TCF7L2/ESR2/NFKB1/RELA",32
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","7/99","25/2914",1.22912756014514e-05,0.000129263248408597,8.38825650695541e-05,"ESR1/UBE2I/CREBBP/EGFR/MYC/SUMO1/MYBL2",7
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","5/99","11/2914",1.60795642598958e-05,0.00016565630983388,0.000107499048336607,"CDC25A/E2F1/E2F4/MYC/RBL1",5
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","11/99","70/2914",1.62768481928693e-05,0.00016565630983388,0.000107499048336607,"MAPK3/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/PIK3R1/STAT3/ELK1/MAPK1/SHC1/MAPK14",11
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","6/99","18/2914",1.76244774694188e-05,0.000176524528304814,0.0001145517416141,"MAPK3/RPS6KA1/RPS6KA2/CREB1/EGFR/MAPK1",6
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","8/99","36/2914",1.84160587823219e-05,0.000181570829556955,0.000117826428722422,"NCOR2/E2F4/MYC/RBL1/SMAD3/SMAD4/WWTR1/PARP1",8
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","10/99","59/2914",2.04242999554481e-05,0.000198272819567504,0.000128664820771973,"AKT1/CSNK2A1/JUN/MAPK3/TP53/EGR1/MAPK1/AKT3/PPARG/ATF2",10
"R-HSA-69206","R-HSA-69206","G1/S Transition","10/99","60/2914",2.38248102610363e-05,0.000227779625374453,0.000147812618684898,"AKT1/CCNE1/CDC25A/CDK2/CDK4/E2F1/E2F4/MYC/RBL1/AKT3",10
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","6/99","19/2914",2.50553673306571e-05,0.00023596920575589,0.000153127068210929,"AR/MAPK3/MAPK1/WWTR1/YAP1/RUNX2",6
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","5/99","12/2914",2.68249764962791e-05,0.000248920002487531,0.000161531205217532,"WWTR1/YAP1/KAT2B/RUNX2/TEAD1",5
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","7/99","28/2914",2.78370570103369e-05,0.000254567869181487,0.000165196265095668,"AR/ESR1/UBE2I/NR3C1/RARA/SUMO1/PPARG",7
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","11/99","77/2914",4.12190310093027e-05,0.000371560122383857,0.000241115835528101,"AKT1/CCNE1/CDC25A/CDK2/CDK4/E2F1/E2F4/MYC/RBL1/AKT3/MYBL2",11
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","8/99","40/2914",4.18170364615549e-05,0.000371641549397762,0.000241168675812377,"CDK4/NCOR2/CREBBP/NR2F2/PPARG/CEBPA/NFKB1/RELA",8
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","7/99","30/2914",4.52578758353502e-05,0.000396634995168139,0.00025738762719227,"CCNE1/CDK2/E2F1/TP53/E2F4/RBL1/SFN",7
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","18/99","191/2914",5.03359411310112e-05,0.000435095600735179,0.000282345798124922,"AKT1/CCNE1/CDC25A/CDK2/CDK4/CSNK1E/CSNK2A1/E2F1/MAPK3/PRKACA/TP53/E2F4/MYC/RBL1/MAPK1/AKT3/MYBL2/FOXM1",18
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","13/99","108/2914",5.15781318576622e-05,0.00043980812435385,0.000285403887519639,"AKT1/CSNK1E/CSNK2A1/CTNNB1/DVL1/YWHAZ/CREBBP/LEF1/MYC/CTBP1/TCF7/TCF7L2/SOX6",13
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","12/99","94/2914",5.70815065958246e-05,0.000480245742159538,0.000311644997414397,"AKT1/FOXO1/TP53/GATA3/MYC/PIK3R1/PTGS2/STAT3/TWIST1/FOXO3/FOS/POU2F1",12
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","6/99","22/2914",6.34134103081747e-05,0.000526498182953397,0.000341659509832132,"CTNNB1/CREBBP/LEF1/MYC/TCF7/TCF7L2",6
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","7/99","32/2914",7.07566447056166e-05,0.000579836919600572,0.000376272519350442,"JUN/MAPK3/TP53/EGR1/MAPK1/PPARG/ATF2",7
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","6/99","23/2914",8.34547408178359e-05,0.0006751274545648,0.000438109233173255,"CDK4/E2F1/MAPK3/TP53/MAPK1/MDM2",6
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","5/99","15/2914",9.37461899481685e-05,0.000748782858953093,0.000485906300997169,"AKT1/YWHAQ/YWHAZ/SFN/AKT3",5
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","6/99","24/2914",0.000108239317158563,0.000843197643543865,0.00054717471572035,"E2F4/MYC/RBL1/SMAD3/SMAD4/WWTR1",6
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","6/99","24/2914",0.000108239317158563,0.000843197643543865,0.00054717471572035,"AKT1/FOXO1/CREB1/AKT3/MDM2/FOXO3",6
"R-HSA-109581","R-HSA-109581","Apoptosis","12/99","101/2914",0.000116848497180773,0.000889029145485682,0.000576916069053182,"AKT1/CTNNB1/E2F1/MAPK3/MAPK8/TP53/YWHAQ/YWHAZ/STAT3/MAPK1/SFN/AKT3",12
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","11/99","86/2914",0.000116940442274662,0.000889029145485682,0.000576916069053182,"CSNK2A1/ESR1/CREBBP/GATA3/SPI1/YAP1/KAT2B/GATA2/KMT2A/RUNX2/MYB",11
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","12/99","103/2914",0.000141629380532952,0.0010639064180511,0.000690398859991457,"AKT1/CTNNB1/E2F1/MAPK3/MAPK8/TP53/YWHAQ/YWHAZ/STAT3/MAPK1/SFN/AKT3",12
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","11/99","89/2914",0.000160333108579861,0.00119023754722226,0.000772378690248496,"MAPK3/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/PIK3R1/STAT3/ELK1/MAPK1/SHC1/MAPK14",11
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","9/99","62/2914",0.000190297037353073,0.00139624919267197,0.000906065453247803,"CDC25A/CDK2/TP53/YWHAQ/YWHAZ/ATR/TOPBP1/SFN/SUMO1",9
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","6/99","27/2914",0.000219114699515292,0.00158921121142701,0.00103128394569206,"GATA3/SPI1/YAP1/GATA2/KMT2A/MYB",6
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","4/99","10/2914",0.000225034130820226,0.0015954667027816,0.00103534331033788,"E2F1/E2F4/RBL1/MYBL2",4
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","4/99","10/2914",0.000225034130820226,0.0015954667027816,0.00103534331033788,"FOXO1/CREBBP/KAT2B/FOXO3",4
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","5/99","19/2914",0.000325667612340238,0.00225820069655704,0.00146541007750553,"PRKACA/RPS6KA5/CREBBP/NFKB1/RELA",5
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","5/99","19/2914",0.000325667612340238,0.00225820069655704,0.00146541007750553,"FOXO1/NR3C1/SMAD3/SMAD4/FOXO3",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","8/99","53/2914",0.000334325388567729,0.00229303608898084,0.00148801574545591,"CSNK2A1/MAPK3/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/EGFR/MAPK1",8
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","4/99","11/2914",0.000344436740283272,0.00233656530835044,0.00151626308273971,"CCNE1/CDK2/E2F1/TP53",4
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","11/99","97/2914",0.000348077874778037,0.00233656530835044,0.00151626308273971,"AKT1/ESR1/FOXO1/CREB1/EGFR/PIK3R1/VAV1/AKT3/MDM2/FOXO3/ESR2",11
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","26/99","393/2914",0.000418945629640542,0.00277783348724205,0.00180261444079933,"AR/CDC25A/ESR1/FBXW7/NCOR2/TP53/UBE2I/CREBBP/GATA3/MYC/NR3C1/PRKDC/SMAD3/SMAD4/APP/CTBP1/KAT2B/MDM2/NRIP1/PARP1/RARA/SUMO1/TRAF6/ZBTB16/PPARG/RELA",26
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","5/99","20/2914",0.000422618089976604,0.00277783348724205,0.00180261444079933,"RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/MAPK1",5
"R-HSA-69242","R-HSA-69242","S Phase","9/99","71/2914",0.00054183289487949,0.00352470676978307,0.00228728156384288,"AKT1/CCNE1/CDC25A/CDK2/CDK4/E2F1/E2F4/MYC/AKT3",9
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","5/99","22/2914",0.000680004131945839,0.00437839395161045,0.00284126323659432,"MAPK3/RPS6KA1/RPS6KA2/CREB1/MAPK1",5
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","7/99","46/2914",0.000761265889704674,0.00480358776403649,0.00311718348521177,"AR/ESR1/NCOR2/NR3C1/RARA/ESR2/PPARG",7
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","7/99","46/2914",0.000761265889704674,0.00480358776403649,0.00311718348521177,"TP53/YWHAQ/YWHAZ/ATR/TOPBP1/SFN/SUMO1",7
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","5/99","23/2914",0.000845712296148061,0.00528360850365769,0.00342868247213753,"E2F1/JUN/TP53/CREBBP/KAT2B",5
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","7/99","47/2914",0.000869915184798833,0.0053292862292045,0.00345832403563358,"AKT1/CCNE1/CDK2/CDK4/EGFR/NR3C1/STAT3",7
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","7/99","47/2914",0.000869915184798833,0.0053292862292045,0.00345832403563358,"AKT1/CCNE1/CDK2/CDK4/EGFR/NR3C1/STAT3",7
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","6/99","35/2914",0.000963744088784386,0.00580271002244464,0.00376554207812322,"AKT1/TP53/YWHAQ/YWHAZ/SFN/AKT3",6
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","4/99","14/2914",0.000965585661421058,0.00580271002244464,0.00376554207812322,"FOXO1/SMAD3/SMAD4/FOXO3",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","5/99","24/2914",0.00103978413272424,0.00613181110045792,0.00397910504308638,"AKT1/FOXO1/CREBBP/AKT3/KAT2B",5
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","5/99","24/2914",0.00103978413272424,0.00613181110045792,0.00397910504308638,"CCNE1/CDC25A/CDK2/TP53/MDM2",5
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","8/99","63/2914",0.00110320913036405,0.00644560149314553,0.00418273247282277,"NCOR2/E2F4/MYC/RBL1/SMAD3/SMAD4/WWTR1/PARP1",8
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","4/99","15/2914",0.00128261819650211,0.00722617930350742,0.00468927141390339,"TP53/E2F4/RBL1/SFN",4
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","4/99","15/2914",0.00128261819650211,0.00722617930350742,0.00468927141390339,"CCNE1/E2F1/E2F4/RBL1",4
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","4/99","15/2914",0.00128261819650211,0.00722617930350742,0.00468927141390339,"CDC25A/JUN/APP/FOXO3",4
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","4/99","15/2914",0.00128261819650211,0.00722617930350742,0.00468927141390339,"CDC25A/JUN/APP/FOXO3",4
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","6/99","37/2914",0.00130644226033402,0.00724469505196447,0.00470128680492815,"NCOR2/UBE2I/CREBBP/CTBP1/NRIP1/SUMO1",6
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","9/99","80/2914",0.00130886725186046,0.00724469505196447,0.00470128680492815,"AR/CDC25A/TP53/GATA3/MYC/SMAD3/SMAD4/MDM2/TRAF6",9
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","11/99","114/2914",0.00139048773030032,0.00762954572016959,0.00495102725022266,"CCNE1/CDC25A/CDK2/TP53/YWHAQ/YWHAZ/ATR/TOPBP1/SFN/MDM2/SUMO1",11
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","9/99","81/2914",0.00143153833333384,0.00778707489942803,0.00505325237447244,"CDK2/MAPK8/TP53/UBE2I/ATR/PRKDC/TOPBP1/PARP1/SUMO1",9
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","5/99","26/2914",0.00152459591443682,0.00822239335050969,0.00533574278646804,"ESR1/FBXW7/NR3C1/TWIST1/RUNX2",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","7/99","52/2914",0.00161010928981105,0.00860999120229469,0.00558726595661462,"CSNK1E/PER2/CREB1/CREBBP/NR3C1/NRIP1/ATF2",7
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","10/99","99/2914",0.00163198185065098,0.00865361804840979,0.00561557664664511,"AKT1/ESR1/MAPK3/EGFR/PIK3R1/VAV1/MAPK1/AKT3/TRAF6/ESR2",10
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","4/99","16/2914",0.00166592245157596,0.00871640295009281,0.00565631953888749,"TP53/UBE2I/MDM2/SUMO1",4
"R-HSA-195721","R-HSA-195721","Signaling by WNT","14/99","172/2914",0.00167144969407485,0.00871640295009281,0.00565631953888749,"AKT1/CSNK1E/CSNK2A1/CTNNB1/DVL1/ROR2/YWHAZ/CREBBP/LEF1/MYC/CTBP1/TCF7/TCF7L2/SOX6",14
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","8/99","68/2914",0.00183016262708995,0.00946584112863738,0.0061426510952372,"CDC25A/CDK2/CSNK1E/E2F1/PRKACA/TP53/MYBL2/FOXM1",8
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","6/99","40/2914",0.00198634422066675,0.0101901073434205,0.00661264785485122,"AKT1/FBXW7/YWHAZ/CREBBP/SMAD3/KAT2B",6
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","7/99","56/2914",0.00249745766827684,0.0126129016935762,0.00818486739311223,"CDK2/CSNK2A1/TP53/ATR/TOPBP1/MAPK14/MDM2",7
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","5/99","29/2914",0.00253857133927761,0.0126129016935762,0.00818486739311223,"E2F1/JUN/TP53/CREBBP/KAT2B",5
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","5/99","29/2914",0.00253857133927761,0.0126129016935762,0.00818486739311223,"AKT1/CDK2/TP53/AKT3/MDM2",5
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","5/99","29/2914",0.00253857133927761,0.0126129016935762,0.00818486739311223,"AKT1/CDK2/TP53/AKT3/MDM2",5
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","11/99","124/2914",0.00275225298477044,0.0135677471358605,0.0088044935121357,"AR/CDC25A/ESR1/TP53/GATA3/MYC/SMAD3/SMAD4/KAT2B/MDM2/TRAF6",11
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","5/99","30/2914",0.00296536299070156,0.0145049926134316,0.00941269851801637,"CCNE1/CSNK2A1/FBXW7/TP53/STAT3",5
"R-HSA-391251","R-HSA-391251","Protein folding","5/99","31/2914",0.00344176410592858,0.0166107824140371,0.0107792048695645,"CCNE1/CSNK2A1/FBXW7/TP53/STAT3",5
"R-HSA-168249","R-HSA-168249","Innate Immune System","25/99","428/2914",0.00344851425711388,0.0166107824140371,0.0107792048695645,"CTNNB1/JUN/MAPK3/MAPK8/PRKACA/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/CREBBP/PIK3R1/PRKDC/SYK/VAV1/APP/ELK1/MAPK1/MAPK10/SHC1/MAPK14/TRAF6/FOS/NFKB1/RELA/ATF2",25
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","9/99","92/2914",0.00349665871021452,0.016715088228374,0.0108468918522604,"AKT1/ESR1/MAPK3/EGFR/PIK3R1/VAV1/MAPK1/TRAF6/ESR2",9
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","6/99","45/2914",0.00367483464454376,0.0174347418098279,0.0113138953441039,"PRKACA/YWHAZ/PIK3R1/SYK/VAV1/SHC1",6
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","3/99","10/2914",0.00383696306707737,0.0176724357323052,0.011468141629605,"TRAF6/NFKB1/RELA",3
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","3/99","10/2914",0.00383696306707737,0.0176724357323052,0.011468141629605,"UBE2I/SUMO1/RELA",3
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","3/99","10/2914",0.00383696306707737,0.0176724357323052,0.011468141629605,"AKT1/TP53/AKT3",3
"R-HSA-74749","R-HSA-74749","Signal attenuation","3/99","10/2914",0.00383696306707737,0.0176724357323052,0.011468141629605,"MAPK3/MAPK1/SHC1",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","4/99","20/2914",0.00399447779236903,0.0181332049423371,0.0117671477563919,"NCOR2/SMAD3/SMAD4/PARP1",4
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/99","20/2914",0.00399447779236903,0.0181332049423371,0.0117671477563919,"CSNK2A1/MAPK3/EGFR/MAPK1",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","9/99","95/2914",0.00434630287331724,0.0195894079504513,0.0127121189302286,"AKT1/CDK2/CSNK2A1/TP53/ATR/TOPBP1/AKT3/MAPK14/MDM2",9
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","6/99","47/2914",0.00458630236357023,0.0205245162511547,0.0133189370618053,"MAPK3/PRKACA/RPS6KA1/RPS6KA2/CREB1/MAPK1",6
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","4/99","21/2914",0.0048073267136257,0.0213621349035057,0.0138624914129014,"APP/TRAF6/NFKB1/RELA",4
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","8/99","80/2914",0.00512919521774561,0.0220210763386986,0.0142900970819147,"CSNK1E/PRKACA/SMO/CREB1/CREBBP/MAPK14/NRF1/ATF2",8
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","3/99","11/2914",0.00514666043962516,0.0220210763386986,0.0142900970819147,"TRAF6/NFKB1/RELA",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/99","11/2914",0.00514666043962516,0.0220210763386986,0.0142900970819147,"AKT1/FOXO1/AKT3",3
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","3/99","11/2914",0.00514666043962516,0.0220210763386986,0.0142900970819147,"YWHAQ/YWHAZ/SFN",3
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/99","34/2914",0.00519990550628541,0.0220210763386986,0.0142900970819147,"CTNNB1/CREBBP/PRKDC/NFKB1/RELA",5
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","5/99","34/2914",0.00519990550628541,0.0220210763386986,0.0142900970819147,"FOXO1/JUN/PRKACA/MYC/FOXO3",5
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","5/99","34/2914",0.00519990550628541,0.0220210763386986,0.0142900970819147,"JUN/TP53/ATR/FOS/ATF2",5
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","6/99","49/2914",0.00565480796609599,0.0236089248400583,0.0153204967266372,"MAPK3/PRKACA/RPS6KA1/RPS6KA2/CREB1/MAPK1",6
"R-HSA-1500620","R-HSA-1500620","Meiosis","4/99","22/2914",0.00572450950955456,0.0236089248400583,0.0153204967266372,"CDK2/CDK4/UBE2I/ATR",4
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","4/99","22/2914",0.00572450950955456,0.0236089248400583,0.0153204967266372,"CCNE1/CDK2/TP53/MDM2",4
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","4/99","22/2914",0.00572450950955456,0.0236089248400583,0.0153204967266372,"CCNE1/CDK2/TP53/MDM2",4
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","10/99","119/2914",0.00633237440062085,0.0258726112292808,0.0167894666247231,"CSNK2A1/NCOR2/PRKACA/UBE2I/CREBBP/PIK3R1/PTGS2/NRF1/ARNT/PPARG",10
"R-HSA-69275","R-HSA-69275","G2/M Transition","7/99","66/2914",0.00635539578532255,0.0258726112292808,0.0167894666247231,"CDC25A/CDK2/CSNK1E/PRKACA/TP53/MYBL2/FOXM1",7
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","3/99","12/2914",0.00669446637877462,0.027078258237223,0.0175718449483355,"APP/NFKB1/RELA",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","5/99","37/2914",0.00751618800690818,0.0302083734545163,0.0196030649325329,"CTNNB1/LEF1/CTBP1/TCF7/TCF7L2",5
"R-HSA-1474165","R-HSA-1474165","Reproduction","4/99","24/2914",0.00789399282830753,0.0313130931490526,0.0203199486779238,"CDK2/CDK4/UBE2I/ATR",4
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","4/99","24/2914",0.00789399282830753,0.0313130931490526,0.0203199486779238,"AR/YWHAQ/YWHAZ/SFN",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","8/99","86/2914",0.00793992853224788,0.0313130931490526,0.0203199486779238,"NCOR2/E2F4/MYC/RBL1/SMAD3/SMAD4/WWTR1/PARP1",8
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","5/99","38/2914",0.00842631758278771,0.0326672956308088,0.0211987288354068,"CREB1/CREBBP/MAPK14/NRF1/ATF2",5
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","3/99","13/2914",0.00849039062353827,0.0326672956308088,0.0211987288354068,"TRAF6/NFKB1/RELA",3
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","3/99","13/2914",0.00849039062353827,0.0326672956308088,0.0211987288354068,"AKT1/AKT3/MDM2",3
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","3/99","13/2914",0.00849039062353827,0.0326672956308088,0.0211987288354068,"FOXO1/CREBBP/FOXO3",3
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/99","25/2914",0.0091566399401319,0.035017210922565,0.0227236550986367,"AKT1/CTNNB1/VAV1/AKT3",4
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","7/99","72/2914",0.0101833867376078,0.0387091387435573,0.0251194511155956,"PRKACA/RPS6KA5/CREBBP/SYK/TRAF6/NFKB1/RELA",7
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","5/99","40/2914",0.0104708361443857,0.0389090257229573,0.0252491634101766,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","3/99","14/2914",0.0105426101586611,0.0389090257229573,0.0252491634101766,"EGFR/PIK3R1/SHC1",3
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","3/99","14/2914",0.0105426101586611,0.0389090257229573,0.0252491634101766,"EGFR/PIK3R1/SHC1",3
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/99","14/2914",0.0105426101586611,0.0389090257229573,0.0252491634101766,"AKT1/TP53/AKT3",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","4/99","26/2914",0.0105442843084401,0.0389090257229573,0.0252491634101766,"AKT1/YWHAQ/YWHAZ/SFN",4
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","4/99","27/2914",0.0120613257202461,0.0442482356364843,0.0287139272042579,"APP/TRAF6/NFKB1/RELA",4
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/99","15/2914",0.0128576081492009,0.04636086138369,0.0300848695942204,"SMAD3/SMAD4/FOXO3",3
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","3/99","15/2914",0.0128576081492009,0.04636086138369,0.0300848695942204,"PIK3R1/SYK/SHC1",3
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","3/99","15/2914",0.0128576081492009,0.04636086138369,0.0300848695942204,"AKT1/FBXW7/YWHAZ",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","7/99","77/2914",0.0144812909353568,0.0519187192057393,0.0336915201785513,"MAPK3/PRKACA/RPS6KA1/RPS6KA2/CREB1/MAPK1/MDM2",7
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","3/99","16/2914",0.0154403048486528,0.0535543596625599,0.034752933370149,"EGFR/PIK3R1/SHC1",3
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","3/99","16/2914",0.0154403048486528,0.0535543596625599,0.034752933370149,"CDC25A/CDK2/ATR",3
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","3/99","16/2914",0.0154403048486528,0.0535543596625599,0.034752933370149,"EGFR/PIK3R1/SHC1",3
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/99","16/2914",0.0154403048486528,0.0535543596625599,0.034752933370149,"MAPK3/MAPK1/MAPK14",3
"R-HSA-622312","R-HSA-622312","Inflammasomes","3/99","16/2914",0.0154403048486528,0.0535543596625599,0.034752933370149,"APP/NFKB1/RELA",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","5/99","44/2914",0.0155316130241656,0.0535543596625599,0.034752933370149,"AKT1/EGFR/PIK3R1/SHC1/AKT3",5
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","5/99","44/2914",0.0155316130241656,0.0535543596625599,0.034752933370149,"ESR1/EGFR/PIK3R1/SHC1/YAP1",5
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","6/99","62/2914",0.0174422480411753,0.0598155354020738,0.0388159867735536,"CDK2/PRKACA/TP53/GATA3/GATA2/MYB",6
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","3/99","17/2914",0.0182941808821199,0.0620625168635357,0.0402741163732011,"UBE2I/MDM2/SUMO1",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/99","17/2914",0.0182941808821199,0.0620625168635357,0.0402741163732011,"CREBBP/SMAD3/KAT2B",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","6/99","63/2914",0.0187618255938632,0.0633086200520198,0.0410827478525911,"CDK2/UBE2I/ATR/TOPBP1/PARP1/SUMO1",6
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","4/99","31/2914",0.019499917720515,0.0654491919236433,0.0424718252703265,"AKT1/PIK3R1/VAV1/AKT3",4
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","7/99","82/2914",0.0199480562697546,0.0665990661704504,0.0432180110773296,"MAPK8/SMAD3/STAT3/APP/TRAF6/NFKB1/RELA",7
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","5/99","47/2914",0.0202538677646521,0.0672641608394497,0.0436496097531837,"NCOR2/CREBBP/NRF1/ARNT/PPARG",5
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/99","18/2914",0.0214213932877258,0.0701619296263068,0.0455300535901799,"CDC25A/CDK2/FOXM1",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/99","18/2914",0.0214213932877258,0.0701619296263068,0.0455300535901799,"CREBBP/KAT2B/IKZF1",3
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","4/99","32/2914",0.0217183475444814,0.0701619296263068,0.0455300535901799,"CREB1/CREBBP/NRF1/ATF2",4
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","4/99","32/2914",0.0217183475444814,0.0701619296263068,0.0455300535901799,"MAPK3/RPS6KA5/CREB1/MAPK1",4
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","19/99","347/2914",0.0218508930110363,0.0701619296263068,0.0455300535901799,"AKT1/CTNNB1/ESR1/MAPK3/PRKACA/RPS6KA1/RPS6KA2/RPS6KA5/CREB1/EGFR/PIK3R1/STAT3/VAV1/ELK1/MAPK1/SHC1/YAP1/AKT3/MAPK14",19
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","5/99","48/2914",0.0220159462218839,0.0701619296263068,0.0455300535901799,"APP/MAPK14/TRAF6/NFKB1/RELA",5
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","5/99","48/2914",0.0220159462218839,0.0701619296263068,0.0455300535901799,"NCOR2/CREBBP/NRF1/ARNT/PPARG",5
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","5/99","48/2914",0.0220159462218839,0.0701619296263068,0.0455300535901799,"CDK2/UBE2I/ATR/TOPBP1/SUMO1",5
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","7/99","85/2914",0.0238479961169269,0.0756185203506577,0.0490709891006854,"AKT1/CTNNB1/PRKACA/PIK3R1/VAV1/AKT3/MAPK14",7
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","4/99","33/2914",0.0240855786988596,0.0759900007949022,0.0493120532308232,"MAPK3/MAPK1/SHC1/MAPK14",4
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","4/99","34/2914",0.0266036684578695,0.0835169890393814,0.0541965280445732,"MAPK8/TP53/UBE2I/SUMO1",4
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","5/99","51/2914",0.0278917011779221,0.085435259433344,0.0554413477680721,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","5/99","51/2914",0.0278917011779221,0.085435259433344,0.0554413477680721,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","5/99","51/2914",0.0278917011779221,0.085435259433344,0.0554413477680721,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","5/99","51/2914",0.0278917011779221,0.085435259433344,0.0554413477680721,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","5/99","51/2914",0.0278917011779221,0.085435259433344,0.0554413477680721,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","7/99","88/2914",0.0282469187860918,0.0860408832606783,0.0558343541386335,"MAPK3/PRKACA/RPS6KA1/RPS6KA2/CREB1/MAPK1/MDM2",7
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","3/99","20/2914",0.0284984858977524,0.0860408832606783,0.0558343541386335,"MAPK8/MAPK10/TRAF6",3
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","3/99","20/2914",0.0284984858977524,0.0860408832606783,0.0558343541386335,"PIK3R1/SYK/VAV1",3
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","4/99","35/2914",0.0292743440770524,0.0879624338696193,0.0570813024860821,"MAPK8/TP53/UBE2I/SUMO1",4
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","8/99","109/2914",0.0299797251521514,0.0892321064670165,0.0579052288192,"CDK4/NCOR2/CREBBP/KAT2B/KMT2A/NFKB1/RELA/ATF2",8
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","8/99","109/2914",0.0299797251521514,0.0892321064670165,0.0579052288192,"CDK4/NCOR2/CREBBP/KAT2B/KMT2A/NFKB1/RELA/ATF2",8
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","9/99","130/2914",0.0305160892118303,0.0904021234397414,0.058664485808757,"AR/CTNNB1/DVL1/MAPK3/YWHAQ/YWHAZ/MAPK1/SFN/MAPK14",9
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/99","21/2914",0.0324470124284401,0.0956732001978772,0.0620850360780286,"AKT1/PIK3R1/AKT3",3
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","10/99","153/2914",0.0327584733809418,0.0961423102482526,0.062389454811194,"AKT1/MAPK3/YWHAZ/PIK3R1/SYK/VAV1/APP/MAPK1/SHC1/MAPK14",10
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","7/99","92/2914",0.0349311499405984,0.101535262696347,0.0658890936506446,"AKT1/CTNNB1/PRKACA/PIK3R1/VAV1/AKT3/MAPK14",7
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","4/99","37/2914",0.0350787436890707,0.101535262696347,0.0658890936506446,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","4/99","37/2914",0.0350787436890707,0.101535262696347,0.0658890936506446,"CREBBP/EGFR/KAT2B/IKZF1",4
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","3/99","22/2914",0.03666635499458,0.10421833334045,0.0676302138117194,"EGFR/PIK3R1/SHC1",3
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","3/99","22/2914",0.03666635499458,0.10421833334045,0.0676302138117194,"CCNE1/CDK2/CDK4",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/99","22/2914",0.03666635499458,0.10421833334045,0.0676302138117194,"CTNNB1/MAPK14/MYOD1",3
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","3/99","22/2914",0.03666635499458,0.10421833334045,0.0676302138117194,"NCOR2/PRKACA/CREB1",3
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","4/99","38/2914",0.0382143232309863,0.108131111922656,0.070169326112125,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-109582","R-HSA-109582","Hemostasis","16/99","298/2914",0.0409593335907706,0.115380979891858,0.0748739697688428,"AKT1/CDK2/MAPK3/PRKACA/TP53/YWHAZ/GATA3/PIK3R1/SYK/VAV1/APP/MAPK1/SHC1/MAPK14/GATA2/MYB",16
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","6/99","76/2914",0.0424737373971677,0.119115236878279,0.0772972343742608,"CTNNB1/DVL1/ROR2/LEF1/TCF7/TCF7L2",6
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/99","10/2914",0.0430468720348997,0.119134106377288,0.0773094793239889,"MAPK3/MAPK1",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","2/99","10/2914",0.0430468720348997,0.119134106377288,0.0773094793239889,"UBE2I/ATR",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/99","10/2914",0.0430468720348997,0.119134106377288,0.0773094793239889,"MAPK3/MAPK1",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","4/99","40/2914",0.0449545898694423,0.12170593295778,0.0789784100768647,"CTNNB1/LEF1/TCF7/TCF7L2",4
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/99","40/2914",0.0449545898694423,0.12170593295778,0.0789784100768647,"CDK4/E2F1/E2F4/RBL1",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/99","40/2914",0.0449545898694423,0.12170593295778,0.0789784100768647,"CDK4/E2F1/E2F4/RBL1",4
"R-HSA-422475","R-HSA-422475","Axon guidance","14/99","254/2914",0.0454984049442042,0.12170593295778,0.0789784100768647,"CSNK2A1/MAPK3/MAPK8/PRKACA/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/CREB1/EGFR/PIK3R1/MAPK1/SHC1/MAPK14",14
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","3/99","24/2914",0.0459049319238538,0.12170593295778,0.0789784100768647,"PIK3R1/SYK/SHC1",3
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","3/99","24/2914",0.0459049319238538,0.12170593295778,0.0789784100768647,"PIK3R1/SYK/SHC1",3
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","3/99","24/2914",0.0459049319238538,0.12170593295778,0.0789784100768647,"CCNE1/CDK2/TP53",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/99","24/2914",0.0459049319238538,0.12170593295778,0.0789784100768647,"AKT1/EGFR/AKT3",3
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","3/99","24/2914",0.0459049319238538,0.12170593295778,0.0789784100768647,"PIK3R1/VAV1/SHC1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/99","24/2914",0.0459049319238538,0.12170593295778,0.0789784100768647,"MAPK3/STAT3/MAPK1",3
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","5/99","59/2914",0.048119209404669,0.126615456595248,0.0821643383360607,"CDK2/UBE2I/ATR/TOPBP1/SUMO1",5
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","4/99","41/2914",0.0485593351759906,0.126615456595248,0.0821643383360607,"PIK3R1/STAT3/SYK/SHC1",4
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","4/99","41/2914",0.0485593351759906,0.126615456595248,0.0821643383360607,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","4/99","41/2914",0.0485593351759906,0.126615456595248,0.0821643383360607,"NCOR2/PRKACA/CREB1/PPARG",4
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","3/99","25/2914",0.0509160626489067,0.13095575865566,0.0849808826708675,"AKT1/SYK/SHC1",3
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/99","25/2914",0.0509160626489067,0.13095575865566,0.0849808826708675,"AKT1/CSNK2A1/AKT3",3
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","3/99","25/2914",0.0509160626489067,0.13095575865566,0.0849808826708675,"AKT1/SYK/SHC1",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","2/99","11/2914",0.0514691412782941,0.13095575865566,0.0849808826708675,"AKT1/AKT3",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/99","11/2914",0.0514691412782941,0.13095575865566,0.0849808826708675,"SMAD4/STAT3",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/99","11/2914",0.0514691412782941,0.13095575865566,0.0849808826708675,"ESR1/EGFR",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/99","26/2914",0.0561819467802718,0.140813417626449,0.0913777954069376,"PRKACA/CREB1/MAPK1",3
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","3/99","26/2914",0.0561819467802718,0.140813417626449,0.0913777954069376,"NCOR2/CREBBP/KAT2B",3
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","4/99","43/2914",0.0562361033943981,0.140813417626449,0.0913777954069376,"PIK3R1/TRAF6/NFKB1/RELA",4
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","4/99","43/2914",0.0562361033943981,0.140813417626449,0.0913777954069376,"MAPK3/SYK/VAV1/MAPK1",4
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","5/99","62/2914",0.0574787925120924,0.143356197925416,0.0930278772090866,"MAPK3/PIK3R1/SYK/VAV1/MAPK1",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"MAPK3/MAPK1",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"SMAD3/SMAD4",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"MAPK3/MAPK1",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"PIK3R1/STAT3",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"MAPK3/MAPK1",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"CREBBP/KAT2B",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"CTNNB1/TCF7L2",2
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"PRKACA/CREB1",2
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"NCOR2/PRKACA",2
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"NCOR2/PRKACA",2
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","2/99","12/2914",0.060424076258198,0.144422697420163,0.0937199587896293,"SYK/SHC1",2
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","5/99","63/2914",0.0608164620740089,0.144724246856733,0.0939156427179398,"PIK3R1/SYK/VAV1/NFKB1/RELA",5
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/99","27/2914",0.0616970244127751,0.144724246856733,0.0939156427179398,"JUN/CREBBP/RARA",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/99","27/2914",0.0616970244127751,0.144724246856733,0.0939156427179398,"JUN/CREBBP/RARA",3
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","3/99","27/2914",0.0616970244127751,0.144724246856733,0.0939156427179398,"ESR1/TP53/TRAF6",3
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","3/99","27/2914",0.0616970244127751,0.144724246856733,0.0939156427179398,"PIK3R1/SYK/VAV1",3
"R-HSA-112316","R-HSA-112316","Neuronal System","7/99","105/2914",0.063637033775993,0.148722104861672,0.0965099654536502,"MAPK3/PRKACA/RPS6KA1/RPS6KA2/CREB1/MAPK1/MDM2",7
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","5/99","64/2914",0.0642629076499222,0.149630607849081,0.0970995186475811,"FBXW7/NCOR2/CREBBP/MYC/KAT2B",5
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","3/99","28/2914",0.0674552468603337,0.15648625282673,0.101548339894233,"PIK3R1/SYK/VAV1",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"PRKACA/CREB1",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"MAPK3/MAPK1",2
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"MAPK8/TRAF6",2
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"UBE2I/SUMO1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"TP53/MDM2",2
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"AKT1/AKT3",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"CREBBP/KAT2B",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/99","13/2914",0.0698665645554088,0.15744929369451,0.102173284255842,"CDK2/CDK4",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","5/99","66/2914",0.0714809524000466,0.160514167133201,0.104162167011119,"CREBBP/APP/TRAF6/NFKB1/RELA",5
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","3/99","29/2914",0.0734501338159721,0.164351185949923,0.106652116664476,"SYK/VAV1/SHC1",3
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","3/99","30/2914",0.0796748266956047,0.174738558235605,0.113392775300109,"UBE2I/PARP1/SUMO1",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/99","14/2914",0.0797538902882002,0.174738558235605,0.113392775300109,"MAPK3/MAPK1",2
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","2/99","14/2914",0.0797538902882002,0.174738558235605,0.113392775300109,"EGFR/SHC1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/99","14/2914",0.0797538902882002,0.174738558235605,0.113392775300109,"CTNNB1/TCF7L2",2
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","2/99","14/2914",0.0797538902882002,0.174738558235605,0.113392775300109,"STAT3/SHC1",2
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","2/99","14/2914",0.0797538902882002,0.174738558235605,0.113392775300109,"VAV1/SHC1",2
"R-HSA-73894","R-HSA-73894","DNA Repair","9/99","157/2914",0.0826855411357961,0.180435921636005,0.11708995498608,"CDK2/MAPK8/TP53/UBE2I/ATR/PRKDC/TOPBP1/PARP1/SUMO1",9
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","4/99","49/2914",0.0829261763461829,0.180435921636005,0.11708995498608,"MAPK3/ATR/CREBBP/MAPK1",4
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","3/99","31/2914",0.0861221383715073,0.185471226322256,0.120357506112866,"KMT2A/NFKB1/RELA",3
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","3/99","31/2914",0.0861221383715073,0.185471226322256,0.120357506112866,"AKT1/YWHAZ/MAPK14",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","3/99","31/2914",0.0861221383715073,0.185471226322256,0.120357506112866,"CTNNB1/CTBP1/TCF7L2",3
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","4/99","50/2914",0.0878907805599851,0.188636335147451,0.122411434435497,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","2/99","15/2914",0.0900456260018923,0.189395966690647,0.12290438075346,"WWTR1/YAP1",2
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","2/99","15/2914",0.0900456260018923,0.189395966690647,0.12290438075346,"AR/NR3C1",2
"R-HSA-392517","R-HSA-392517","Rap1 signalling","2/99","15/2914",0.0900456260018923,0.189395966690647,0.12290438075346,"PRKACA/YWHAZ",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/99","15/2914",0.0900456260018923,0.189395966690647,0.12290438075346,"TP53/CREBBP",2
"R-HSA-69541","R-HSA-69541","Stabilization of p53","2/99","15/2914",0.0900456260018923,0.189395966690647,0.12290438075346,"TP53/MDM2",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/99","15/2914",0.0900456260018923,0.189395966690647,0.12290438075346,"SMAD3/STAT3",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/99","32/2914",0.0927845994915445,0.193864510858161,0.125804145005963,"MAPK3/ATR/MAPK1",3
"R-HSA-8853659","R-HSA-8853659","RET signaling","3/99","32/2914",0.0927845994915445,0.193864510858161,0.125804145005963,"PRKACA/PIK3R1/SHC1",3
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","5/99","72/2914",0.0956940880877273,0.199283727997874,0.129320827744054,"ESR1/EGFR/PIK3R1/VAV1/ESR2",5
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","4/99","52/2914",0.0982425067431583,0.203249251655518,0.131894167810487,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","4/99","52/2914",0.0982425067431583,0.203249251655518,0.131894167810487,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","3/99","33/2914",0.0996545015708129,0.204321308083625,0.132589855441705,"AKT1/SYK/SHC1",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/99","16/2914",0.100703529023784,0.204321308083625,0.132589855441705,"MAPK3/MAPK1",2
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","2/99","16/2914",0.100703529023784,0.204321308083625,0.132589855441705,"NFKB1/RELA",2
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","2/99","16/2914",0.100703529023784,0.204321308083625,0.132589855441705,"EGFR/PIK3R1",2
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","2/99","16/2914",0.100703529023784,0.204321308083625,0.132589855441705,"AKT1/AKT3",2
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","2/99","16/2914",0.100703529023784,0.204321308083625,0.132589855441705,"PIK3R1/SHC1",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","4/99","53/2914",0.103624302226601,0.208903944744362,0.135563657528662,"AKT1/PIK3R1/VAV1/AKT3",4
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","4/99","53/2914",0.103624302226601,0.208903944744362,0.135563657528662,"SYK/TRAF6/NFKB1/RELA",4
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/99","34/2914",0.106723937033356,0.213110140088758,0.138293176235761,"PRKACA/CREB1/MAPK1",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/99","34/2914",0.106723937033356,0.213110140088758,0.138293176235761,"PRKACA/CREB1/MAPK1",3
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","3/99","34/2914",0.106723937033356,0.213110140088758,0.138293176235761,"CREBBP/KAT2B/ATF2",3
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","2/99","17/2914",0.111691442109339,0.220241562409352,0.142920957172805,"EGFR/PIK3R1",2
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","2/99","17/2914",0.111691442109339,0.220241562409352,0.142920957172805,"PIK3R1/SYK",2
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","2/99","17/2914",0.111691442109339,0.220241562409352,0.142920957172805,"PIK3R1/SHC1",2
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","2/99","17/2914",0.111691442109339,0.220241562409352,0.142920957172805,"UBE2I/SUMO1",2
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","5/99","76/2914",0.113893482430389,0.22336780047009,0.144949661160839,"MAPK8/VAV1/TRAF6/NFKB1/RELA",5
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","3/99","35/2914",0.113984836373009,0.22336780047009,0.144949661160839,"PRKACA/WWTR1/KAT2B",3
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","4/99","55/2914",0.114785309192114,0.224240031270044,0.145515676310029,"MAPK3/PIK3R1/MAPK1/SHC1",4
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","4/99","57/2914",0.126455372647902,0.246275741175389,0.159815269525776,"APP/TRAF6/NFKB1/RELA",4
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","2/99","19/2914",0.134522529215581,0.260379496733226,0.168967594009884,"NFKB1/RELA",2
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","2/99","19/2914",0.134522529215581,0.260379496733226,0.168967594009884,"AKT1/AKT3",2
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","3/99","38/2914",0.136833899073415,0.263238385107698,0.170822807251472,"TRAF6/NFKB1/RELA",3
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","3/99","38/2914",0.136833899073415,0.263238385107698,0.170822807251472,"UBE2I/PARP1/SUMO1",3
"R-HSA-202403","R-HSA-202403","TCR signaling","4/99","59/2914",0.13860787086923,0.265840627715758,0.172511475821887,"PIK3R1/TRAF6/NFKB1/RELA",4
"R-HSA-167044","R-HSA-167044","Signalling to RAS","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"SHC1/MAPK14",2
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"NFKB1/RELA",2
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"NFKB1/RELA",2
"R-HSA-70171","R-HSA-70171","Glycolysis","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"PRKACA/GAPDH",2
"R-HSA-70326","R-HSA-70326","Glucose metabolism","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"PRKACA/GAPDH",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"MAPK3/KAT2B",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"MAPK3/KAT2B",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/99","20/2914",0.146302978473118,0.273938217853226,0.177766230285937,"KAT2B/KMT2A",2
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","2/99","21/2914",0.158287817004136,0.293763566263559,0.190631457630368,"AKT1/AKT3",2
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/99","21/2914",0.158287817004136,0.293763566263559,0.190631457630368,"MAPK14/TRAF6",2
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","2/99","21/2914",0.158287817004136,0.293763566263559,0.190631457630368,"UBE2I/SUMO1",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","3/99","41/2914",0.161106835429618,0.298118513654221,0.193457505732741,"PIK3R1/STAT3/VAV1",3
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","3/99","42/2914",0.16947504898833,0.311750512412791,0.202303693933732,"CSNK1E/PRKACA/SMO",3
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","2/99","22/2914",0.170449963205092,0.311750512412791,0.202303693933732,"EGFR/SHC1",2
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/99","22/2914",0.170449963205092,0.311750512412791,0.202303693933732,"PIK3R1/STAT3",2
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","2/99","22/2914",0.170449963205092,0.311750512412791,0.202303693933732,"NCOR2/NRIP1",2
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/99","23/2914",0.182763905935395,0.329497213272098,0.213820028297349,"MAPK3/MAPK1",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/99","23/2914",0.182763905935395,0.329497213272098,0.213820028297349,"UBE2I/SUMO1",2
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","2/99","23/2914",0.182763905935395,0.329497213272098,0.213820028297349,"ATR/TOPBP1",2
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","2/99","23/2914",0.182763905935395,0.329497213272098,0.213820028297349,"ATR/TOPBP1",2
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","2/99","23/2914",0.182763905935395,0.329497213272098,0.213820028297349,"CDK2/E2F1",2
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","3/99","44/2914",0.186577341918347,0.335413967950078,0.217659577166703,"EGFR/PIK3R1/SHC1",3
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","2/99","24/2914",0.195205630845535,0.34605766984628,0.22456657531104,"NFKB1/RELA",2
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/99","24/2914",0.195205630845535,0.34605766984628,0.22456657531104,"CREBBP/ARNT",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/99","24/2914",0.195205630845535,0.34605766984628,0.22456657531104,"PIK3R1/STAT3",2
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","2/99","24/2914",0.195205630845535,0.34605766984628,0.22456657531104,"ATR/TOPBP1",2
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","8/99","165/2914",0.195240143368107,0.34605766984628,0.22456657531104,"MAPK3/RPS6KA1/RPS6KA2/CREB1/EGFR/PIK3R1/APP/MAPK1",8
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","3/99","46/2914",0.204112843631081,0.358174477966904,0.232429513602678,"UBE2I/PARP1/SUMO1",3
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"PRKACA/CREB1",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"PRKACA/CREB1",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"CSNK1E/PRKACA",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"CSNK1E/PRKACA",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"MAPK3/MAPK1",2
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"PIK3R1/SHC1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"MAPK3/MAPK1",2
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"PIK3R1/SHC1",2
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","2/99","25/2914",0.207752549819155,0.358174477966904,0.232429513602678,"AKT1/AKT3",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","7/99","144/2914",0.215215202852512,0.37002940871917,0.240122512289193,"AKT1/YWHAQ/YWHAZ/EGFR/APP/SFN/AKT3",7
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/99","26/2914",0.220383433405728,0.374830044417829,0.243237780095981,"CSNK1E/PRKACA",2
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","2/99","26/2914",0.220383433405728,0.374830044417829,0.243237780095981,"PIK3R1/SHC1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/99","26/2914",0.220383433405728,0.374830044417829,0.243237780095981,"CSNK1E/PRKACA",2
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","2/99","26/2914",0.220383433405728,0.374830044417829,0.243237780095981,"PIK3R1/SHC1",2
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/99","27/2914",0.233078346125165,0.390112563408432,0.253155037394078,"ESR1/YAP1",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/99","27/2914",0.233078346125165,0.390112563408432,0.253155037394078,"CSNK1E/PRKACA",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/99","27/2914",0.233078346125165,0.390112563408432,0.253155037394078,"CSNK1E/PRKACA",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/99","27/2914",0.233078346125165,0.390112563408432,0.253155037394078,"MAPK3/MAPK1",2
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","2/99","27/2914",0.233078346125165,0.390112563408432,0.253155037394078,"PRKDC/SUMO1",2
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","2/99","27/2914",0.233078346125165,0.390112563408432,0.253155037394078,"CCNE1/CDK2",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","10/99","228/2914",0.243257888500055,0.40288708269747,0.261444782999943,"AR/CTNNB1/DVL1/MAPK3/YWHAQ/YWHAZ/VAV1/MAPK1/SFN/MAPK14",10
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","9/99","202/2914",0.24508054666213,0.40288708269747,0.261444782999943,"FOXO1/JUN/MAPK3/PRKACA/EGFR/MYC/MAPK1/SHC1/FOXO3",9
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/99","28/2914",0.245818584530152,0.40288708269747,0.261444782999943,"SMAD3/SMAD4",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/99","28/2914",0.245818584530152,0.40288708269747,0.261444782999943,"CSNK1E/PRKACA",2
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","2/99","28/2914",0.245818584530152,0.40288708269747,0.261444782999943,"PIK3R1/SHC1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/99","28/2914",0.245818584530152,0.40288708269747,0.261444782999943,"MAPK3/MAPK1",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","2/99","28/2914",0.245818584530152,0.40288708269747,0.261444782999943,"UBE2I/CREBBP",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/99","28/2914",0.245818584530152,0.40288708269747,0.261444782999943,"CREBBP/TRAF6",2
"R-HSA-69306","R-HSA-69306","DNA Replication","3/99","51/2914",0.24943085510194,0.407748366759907,0.264599407239309,"CCNE1/CDK2/E2F1",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/99","29/2914",0.258586617916387,0.421623141874006,0.273603139859852,"PIK3R1/STAT3",2
"R-HSA-397014","R-HSA-397014","Muscle contraction","3/99","53/2914",0.267991063535295,0.434598898283843,0.282023473905105,"PRKACA/WWTR1/KAT2B",3
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/99","30/2914",0.271366031575014,0.434598898283843,0.282023473905105,"CSNK2A1/PIK3R1",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/99","30/2914",0.271366031575014,0.434598898283843,0.282023473905105,"PRKACA/CREB1",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/99","30/2914",0.271366031575014,0.434598898283843,0.282023473905105,"CTNNB1/DVL1",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","2/99","30/2914",0.271366031575014,0.434598898283843,0.282023473905105,"TP53/CREBBP",2
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","2/99","30/2914",0.271366031575014,0.434598898283843,0.282023473905105,"PIK3R1/SHC1",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/99","30/2914",0.271366031575014,0.434598898283843,0.282023473905105,"MAPK3/MAPK1",2
"R-HSA-1430728","R-HSA-1430728","Metabolism","12/99","289/2914",0.2730282721231,0.436154024581458,0.283032639189569,"AKT1/CSNK2A1/NCOR2/PRKACA/UBE2I/CREBBP/PIK3R1/PTGS2/GAPDH/NRF1/ARNT/PPARG",12
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","2/99","31/2914",0.284141472485602,0.448164770382201,0.290826750652559,"AKT1/PTGS2",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/99","31/2914",0.284141472485602,0.448164770382201,0.290826750652559,"PIK3R1/STAT3",2
"R-HSA-68886","R-HSA-68886","M Phase","5/99","105/2914",0.28416267465163,0.448164770382201,0.290826750652559,"CSNK1E/CSNK2A1/MAPK3/PRKACA/MAPK1",5
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","3/99","55/2914",0.286713150727536,0.448164770382201,0.290826750652559,"UBE2I/PARP1/SUMO1",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","5/99","106/2914",0.290854449350297,0.448164770382201,0.290826750652559,"MAPK8/VAV1/TRAF6/NFKB1/RELA",5
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"MAPK3",1
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"E2F1",1
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"PIK3R1",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"SYK",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"ARNT",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"SHC1",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"CREB1",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"KAT2B",1
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"PIK3R1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/99","10/2914",0.292621054512626,0.448164770382201,0.290826750652559,"STAT3",1
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/99","56/2914",0.296118140455354,0.45142895163622,0.292944969866527,"CSNK1E/CSNK2A1/PRKACA",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/99","32/2914",0.296898597351872,0.45142895163622,0.292944969866527,"MAPK3/MAPK1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/99","32/2914",0.296898597351872,0.45142895163622,0.292944969866527,"MAPK3/MAPK1",2
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","7/99","160/2914",0.299604428162907,0.452173237833831,0.293427958157245,"AKT1/YWHAQ/YWHAZ/EGFR/APP/SFN/AKT3",7
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","12/99","296/2914",0.301410644550315,0.452173237833831,0.293427958157245,"AKT1/FBXW7/PRKACA/YWHAZ/PIK3R1/SYK/VAV1/AKT3/TRAF6/ZBTB16/NFKB1/RELA",12
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/99","33/2914",0.309624022886134,0.452173237833831,0.293427958157245,"MAPK14/TRAF6",2
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","2/99","33/2914",0.309624022886134,0.452173237833831,0.293427958157245,"ATR/TOPBP1",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","2/99","33/2914",0.309624022886134,0.452173237833831,0.293427958157245,"MAPK3/MAPK1",2
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","2/99","33/2914",0.309624022886134,0.452173237833831,0.293427958157245,"CCNE1/CDK2",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"STAT3",1
"R-HSA-110373","R-HSA-110373","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"PARP1",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"E2F1",1
"R-HSA-163615","R-HSA-163615","PKA activation","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"PRKACA",1
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"PRKDC",1
"R-HSA-199992","R-HSA-199992","trans-Golgi Network Vesicle Budding","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"APP",1
"R-HSA-209543","R-HSA-209543","p75NTR recruits signalling complexes","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"TRAF6",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"CREB1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"CREBBP",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"TP53",1
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"PIK3R1",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"TP53",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"CDC25A",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"CDC25A",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"CDC25A",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"CDK4",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"PTGS2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"STAT3",1
"R-HSA-9013700","R-HSA-9013700","NOTCH4 Activation and Transmission of Signal to the Nucleus","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"YWHAZ",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/99","11/2914",0.316736245836059,0.452173237833831,0.293427958157245,"PIK3R1",1
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/99","34/2914",0.322305278251932,0.458050969767949,0.297242184068283,"MAPK3/MAPK1",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/99","34/2914",0.322305278251932,0.458050969767949,0.297242184068283,"MAPK3/MAPK1",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","3/99","59/2914",0.324432800662526,0.460038420714727,0.2985318970023,"PRKACA/CREB1/MAPK1",3
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","2/99","35/2914",0.334930759577928,0.461427030567296,0.299433005072447,"MAPK8/MAPK14",2
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","2/99","35/2914",0.334930759577928,0.461427030567296,0.299433005072447,"PRKACA/SMO",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CREB1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CSNK2A1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"SHC1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"VAV1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CTNNB1",1
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"RARA",1
"R-HSA-5620920","R-HSA-5620920","Cargo trafficking to the periciliary membrane","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"SMO",1
"R-HSA-5635838","R-HSA-5635838","Activation of SMO","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"SMO",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CSNK1E",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CDK2",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CSNK1E",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CSNK1E",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"PRKACA",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"CREB1",1
"R-HSA-937039","R-HSA-937039","IRAK1 recruits IKK complex","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"TRAF6",1
"R-HSA-975110","R-HSA-975110","TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"TRAF6",1
"R-HSA-975144","R-HSA-975144","IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"TRAF6",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/99","12/2914",0.340037352161319,0.461427030567296,0.299433005072447,"TRAF6",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","3/99","61/2914",0.34333262380832,0.464898896186802,0.301685996524591,"MAPK8/VAV1/TRAF6",3
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","3/99","62/2914",0.352772631149563,0.476658523030781,0.309317149818957,"PIK3R1/STAT3/SHC1",3
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/99","37/2914",0.359972060366377,0.480609348309671,0.311880951693156,"CSNK1E/PRKACA",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"CREBBP",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"MAPK14",1
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"EGFR",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"KAT2B",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"POU2F1",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"EGFR",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/99","13/2914",0.362551584461812,0.480609348309671,0.311880951693156,"TRAF6",1
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"SHC1",1
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"ARNT",1
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CREBBP",1
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CDK4",1
"R-HSA-373753","R-HSA-373753","Nephrin family interactions","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"PIK3R1",1
"R-HSA-4641258","R-HSA-4641258","Degradation of DVL","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"DVL1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CTNNB1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CTNNB1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CTNNB1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CTNNB1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CTNNB1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CTNNB1",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"NFKB1",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"EGFR",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"SUMO1",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/99","14/2914",0.384305253244397,0.491350794084615,0.318851378595238,"CREBBP",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","2/99","39/2914",0.384670827698573,0.491350794084615,0.318851378595238,"NFKB1/RELA",2
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","1/99","15/2914",0.405323798047434,0.513572924835202,0.333271945551578,"PIK3R1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/99","15/2914",0.405323798047434,0.513572924835202,0.333271945551578,"MAPK14",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/99","15/2914",0.405323798047434,0.513572924835202,0.333271945551578,"KAT2B",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/99","15/2914",0.405323798047434,0.513572924835202,0.333271945551578,"CTNNB1",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/99","42/2914",0.420935552915474,0.525584492925359,0.341066590621344,"CTNNB1/TCF7L2",2
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","2/99","42/2914",0.420935552915474,0.525584492925359,0.341066590621344,"PTGS2/STAT3",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/99","42/2914",0.420935552915474,0.525584492925359,0.341066590621344,"MAPK3/MAPK1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/99","42/2914",0.420935552915474,0.525584492925359,0.341066590621344,"MAPK3/MAPK1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/99","42/2914",0.420935552915474,0.525584492925359,0.341066590621344,"MAPK3/MAPK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/99","42/2914",0.420935552915474,0.525584492925359,0.341066590621344,"MAPK3/MAPK1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"CTNNB1",1
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"EGFR",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"NCOR2",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"CSNK2A1",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"PARP1",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"TP53",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/99","16/2914",0.425631815982343,0.525584492925359,0.341066590621344,"MDM2",1
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","2/99","44/2914",0.444511929574262,0.538227393447271,0.349270925099655,"DVL1/ROR2",2
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","2/99","44/2914",0.444511929574262,0.538227393447271,0.349270925099655,"CCNE1/CDK2",2
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","2/99","44/2914",0.444511929574262,0.538227393447271,0.349270925099655,"PRKACA/GAPDH",2
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"PRKACA",1
"R-HSA-168927","R-HSA-168927","TICAM1, RIP1-mediated IKK complex recruitment","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"TRAF6",1
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"MDM2",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"MDM2",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"MAPK14",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"RELA",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"PARP1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/99","17/2914",0.445253089349406,0.538227393447271,0.349270925099655,"CDK2",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/99","45/2914",0.456103415054691,0.550289206308814,0.357098175417681,"PIK3R1/STAT3",2
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"PIK3R1",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"PRKACA",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"PRKACA",1
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"SHC1",1
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"PIK3R1",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"CSNK2A1",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/99","18/2914",0.464210612357487,0.552673389429385,0.358645339040839,"E2F1",1
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/99","46/2914",0.467557531937582,0.555609797839198,0.360550857218197,"MAPK3/MAPK1",2
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"CREBBP",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"CREBBP",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"CTNNB1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"PRKACA",1
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"SHC1",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"PIK3R1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"KAT2B",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"NCOR2",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/99","19/2914",0.482526616976481,0.562799067120443,0.365216176678376,"APP",1
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","2/99","48/2914",0.490037692334802,0.570505136279077,0.370216862144568,"MAPK8/VAV1",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/99","20/2914",0.500222597950343,0.57589588873812,0.373715073349118,"CREBBP",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/99","20/2914",0.500222597950343,0.57589588873812,0.373715073349118,"PRKACA",1
"R-HSA-6783310","R-HSA-6783310","Fanconi Anemia Pathway","1/99","20/2914",0.500222597950343,0.57589588873812,0.373715073349118,"ATR",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/99","20/2914",0.500222597950343,0.57589588873812,0.373715073349118,"EGFR",1
"R-HSA-937041","R-HSA-937041","IKK complex recruitment mediated by RIP1","1/99","20/2914",0.500222597950343,0.57589588873812,0.373715073349118,"TRAF6",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/99","49/2914",0.501056803355353,0.57589588873812,0.373715073349118,"PIK3R1/STAT3",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/99","49/2914",0.501056803355353,0.57589588873812,0.373715073349118,"MAPK3/MAPK1",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","4/99","109/2914",0.511752487528924,0.587119672055911,0.380998502677036,"AKT1/CSNK1E/YWHAZ/MAPK14",4
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/99","21/2914",0.517319336997653,0.589221122103825,0.38236219284075,"CTNNB1",1
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","1/99","21/2914",0.517319336997653,0.589221122103825,0.38236219284075,"SHC1",1
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","1/99","21/2914",0.517319336997653,0.589221122103825,0.38236219284075,"PIK3R1",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/99","21/2914",0.517319336997653,0.589221122103825,0.38236219284075,"PARP1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","2/99","51/2914",0.522638665759119,0.592073605195699,0.384213249513932,"PIK3R1/SHC1",2
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","2/99","51/2914",0.522638665759119,0.592073605195699,0.384213249513932,"PIK3R1/SHC1",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","2/99","51/2914",0.522638665759119,0.592073605195699,0.384213249513932,"FBXW7/ZBTB16",2
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PRKACA",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"SMAD3",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PRKACA",1
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PIK3R1",1
"R-HSA-5696400","R-HSA-5696400","Dual Incision in GG-NER","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PARP1",1
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PIK3R1",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/99","22/2914",0.53383692622587,0.596196637961989,0.38688880168023,"PRKDC",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/99","23/2914",0.549794790784528,0.608632478921118,0.39495876937245,"SMAD4",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/99","23/2914",0.549794790784528,0.608632478921118,0.39495876937245,"MAPK14",1
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","1/99","23/2914",0.549794790784528,0.608632478921118,0.39495876937245,"PIK3R1",1
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","1/99","23/2914",0.549794790784528,0.608632478921118,0.39495876937245,"SHC1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/99","23/2914",0.549794790784528,0.608632478921118,0.39495876937245,"STAT3",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/99","55/2914",0.563917951055703,0.6231737777866,0.404395028040683,"PRKACA/SMO",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/99","24/2914",0.565211710781875,0.623511520110775,0.404614198553827,"STAT3",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","2/99","57/2914",0.583592557569653,0.642664753623824,0.417043271598411,"CTNNB1/PIK3R1",2
"R-HSA-182971","R-HSA-182971","EGFR downregulation","1/99","26/2914",0.594494738851973,0.652393356896687,0.423356436454769,"EGFR",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/99","26/2914",0.594494738851973,0.652393356896687,0.423356436454769,"CTNNB1",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/99","27/2914",0.608395369341465,0.665333584149852,0.431753714628897,"AKT1",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/99","27/2914",0.608395369341465,0.665333584149852,0.431753714628897,"PRKDC",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/99","28/2914",0.621824139149292,0.678842615576476,0.440520105862456,"PRKACA",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/99","29/2914",0.634796907764753,0.689426590016452,0.447388345177079,"CREB1",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/99","29/2914",0.634796907764753,0.689426590016452,0.447388345177079,"SHC1",1
"R-HSA-977225","R-HSA-977225","Amyloid fiber formation","1/99","29/2914",0.634796907764753,0.689426590016452,0.447388345177079,"APP",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/99","97/2914",0.648533233946452,0.703134829244349,0.45628400796739,"MAPK3/EGR1/SUMO1",3
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/99","31/2914",0.659435258092313,0.713728383972984,0.463158464201336,"PRKACA",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/99","32/2914",0.67112998908394,0.723902603610198,0.469760802075848,"STAT3",1
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","1/99","32/2914",0.67112998908394,0.723902603610198,0.469760802075848,"PIK3R1",1
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","1/99","33/2914",0.682427050527622,0.734831858161995,0.476853103386465,"SMO",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","2/99","69/2914",0.688002710828064,0.739573612491496,0.479930161413282,"PIK3R1/SHC1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/99","34/2914",0.693339831505673,0.742780023225941,0.482010891708885,"MAPK3",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/99","34/2914",0.693339831505673,0.742780023225941,0.482010891708885,"CDK2",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/99","35/2914",0.703881274797665,0.751521293396492,0.48768334828799,"MAPK3",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/99","35/2914",0.703881274797665,0.751521293396492,0.48768334828799,"CTNNB1",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/99","37/2914",0.72389977580847,0.771589119147203,0.500705926012615,"KAT2B",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/99","40/2914",0.75144199780073,0.798248990929731,0.518006268198624,"CDK2",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/99","40/2914",0.75144199780073,0.798248990929731,0.518006268198624,"CDK2",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/99","42/2914",0.768273979196123,0.812028276168766,0.526948034747936,"PIK3R1",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/99","42/2914",0.768273979196123,0.812028276168766,0.526948034747936,"MAPK14",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/99","42/2914",0.768273979196123,0.812028276168766,0.526948034747936,"EGR1",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","5/99","188/2914",0.777436561397393,0.82033857899959,0.532340824473835,"MAPK3/EGFR/PIK3R1/MAPK1/SHC1",5
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/99","45/2914",0.79142853073852,0.833708519025052,0.541016955377004,"PRKACA",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/99","46/2914",0.798625664045208,0.839887990020877,0.545026988269449,"PIK3R1",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/99","47/2914",0.805576870202643,0.844383729398451,0.547944400260234,"DVL1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/99","47/2914",0.805576870202643,0.844383729398451,0.547944400260234,"SUMO1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/99","125/2914",0.807117218045424,0.844595297821995,0.548081692973152,"MAPK1/MAPK14/NFKB1",3
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","2/99","88/2914",0.808962766860676,0.845125009750143,0.548425437972818,"FBXW7/ZBTB16",2
"R-HSA-3000178","R-HSA-3000178","ECM proteoglycans","1/99","49/2914",0.818774504447921,0.853961507944856,0.554159690700724,"APP",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/99","50/2914",0.8250367467026,0.857657639488205,0.556558214631599,"PIK3R1",1
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/99","50/2914",0.8250367467026,0.857657639488205,0.556558214631599,"APP",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","12/99","436/2914",0.828298978120084,0.859632656568705,0.55783985887935,"AKT1/MAPK3/PRKACA/RPS6KA1/RPS6KA2/CREB1/EGFR/PIK3R1/VAV1/APP/MAPK1/AKT3",12
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/99","53/2914",0.842566585910419,0.871486002282774,0.565531828989906,"CSNK2A1",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/99","53/2914",0.842566585910419,0.871486002282774,0.565531828989906,"EGFR",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","4/99","171/2914",0.843863625031339,0.871486002282774,0.565531828989906,"MAPK3/EGFR/MAPK1/SHC1",4
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/99","55/2914",0.853275342781476,0.879765917148875,0.570904899109037,"PRKACA",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/99","177/2914",0.862736635332016,0.888069848115011,0.576293553952355,"MAPK3/EGFR/MAPK1/SHC1",4
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","13/99","486/2914",0.866147728251322,0.890129017144274,0.577629806771412,"AKT1/MAPK3/PRKACA/RPS6KA1/RPS6KA2/SMO/CREB1/EGFR/PIK3R1/VAV1/APP/MAPK1/AKT3",13
"R-HSA-114608","R-HSA-114608","Platelet degranulation ","1/99","59/2914",0.872576335432301,0.895277508386637,0.580970807844527,"APP",1
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/99","61/2914",0.881261700252163,0.899799567733195,0.583905299604993,"APP",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/99","61/2914",0.881261700252163,0.899799567733195,0.583905299604993,"VAV1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/99","61/2914",0.881261700252163,0.899799567733195,0.583905299604993,"CSNK2A1",1
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","1/99","62/2914",0.885381956710289,0.902546065725675,0.585687579560076,"APP",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/99","64/2914",0.893202547692238,0.909049689667423,0.589907964435112,"PRKACA",1
"R-HSA-373080","R-HSA-373080","Class B/2 (Secretin family receptors)","1/99","65/2914",0.896912353930297,0.911355387004859,0.591404196421537,"SMO",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/99","66/2914",0.90049455012577,0.913524214034342,0.592811609407555,"EGFR",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","2/99","115/2914",0.909701793813683,0.921383357779187,0.59791162928702,"FBXW7/ZBTB16",2
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/99","217/2914",0.945483710136269,0.956090097910234,0.620433811138679,"PRKACA/CREB1/APP/MAPK1",4
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","1/99","106/2914",0.976071647092648,0.985441934904738,0.639481045421541,"VAV1",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/99","121/2914",0.986052519435555,0.993928338280887,0.64498811175455,"PRKACA",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/99","126/2914",0.988356813893717,0.994662120521428,0.64546428373148,"CTNNB1",1
"R-HSA-375276","R-HSA-375276","Peptide ligand-binding receptors","1/99","153/2914",0.995633910413049,0.99939519994771,0.648535712369104,"APP",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","1/99","157/2914",0.996227544797321,0.99939519994771,0.648535712369104,"APP",1
"R-HSA-373076","R-HSA-373076","Class A/1 (Rhodopsin-like receptors)","1/99","248/2914",0.999872119046702,0.999876961139575,0.648848340784544,"APP",1
"R-HSA-500792","R-HSA-500792","GPCR ligand binding","2/99","317/2914",0.999876961139575,0.999876961139575,0.648848340784544,"SMO/APP",2
